Perpetuals.com Ltd (NASDAQ: PDC), an AI-powered fintech company, announced on Tuesday the filing of a U.S. patent application for BayesShield AI, a system designed to identify in real time which AI model or human expert is best suited for a specific decision. The technology addresses reliability and risk-control challenges that have limited enterprise adoption of agentic AI systems, with applications spanning finance, cybersecurity, healthcare, and legal analysis.
According to the press release, BayesShield AI is a decision routing system that dynamically evaluates the strengths and weaknesses of available AI models and human experts before assigning a task. This approach aims to reduce errors and improve outcomes by ensuring that each decision is handled by the most capable entity. For instance, in a financial trading context, the system might route a high-stakes trade to a human expert while delegating routine pattern recognition to a specialized AI model.
The patent filing marks a strategic move by Perpetuals to protect its intellectual property in the rapidly evolving field of agentic AI, where autonomous systems make decisions with minimal human intervention. Industry analysts have noted that one of the biggest barriers to widespread adoption of such systems is the lack of trust in their reliability, especially when they operate in high-stakes environments. BayesShield AI directly targets this issue by introducing a layer of oversight that can switch between AI and human decision-makers as needed.
Perpetuals is known for its proprietary trading platform, Kronos X, which combines advanced AI and data analysis. The platform is trained on billions of trades, monitors market activity in real time, and identifies patterns for trading and risk decisions. It also provides multi-asset coverage with self-clearing blockchain-based settlement. The company’s licensed European Multilateral Trading Facility (MTF) infrastructure and Kronos X platform operate with full MiFID II, MiCA, DORA, and EMIR compliance.
The implications of BayesShield AI extend beyond Perpetuals’ own products. By publishing the patent application, the company signals its intent to license or develop the technology for broader use. If successful, the system could become a standard component in enterprise AI deployments, helping organizations balance automation with human judgment. This is particularly relevant in sectors like healthcare, where diagnostic AI must be validated by human doctors, or cybersecurity, where automated threat detection often requires human verification.
Investors and industry observers will be watching for further developments, as the patent process can take months to years. Perpetuals has not disclosed a timeline for commercialization, but the filing itself is a significant step in establishing the company as a player in the AI infrastructure space. For more information, visit the company’s newsroom at https://nnw.fm/PDC.
This news story relied on content distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Perpetuals Files Patent for BayesShield AI That Routes Decisions to Best Model or Human Expert.